Cover Image

Organoids in gastrointestinal diseases: from bench to clinic

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Qinying Wang, Fanying Guo, Qinyuan Zhang, TingTing Hu, YuTao Jin, Yongzhi Yang, Yanlei Ma
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	MedComm
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine
by: Qigu Yao, et al.
Published: (2024)

Organoid‐Guided Precision Medicine: From Bench to Bedside
by: Boqiang Tao, et al.
Published: (2025)

Therapeutic potential of Parabacteroides distasonis in gastrointestinal and hepatic disease
by: Jingyi Duan, et al.
Published: (2024)

Tumor Organoid and Microenvironment Cocultures: Implications for Basic and Translational Cancer Research
by: Jiajun Yang, et al.
Published: (2026)

Organoids: From Bench to Bedside Applications
by: Kelin Li, et al.
Published: (2026)

Skeletal muscle: molecular structure, myogenesis, biological functions, and diseases
by: Lan‐Ting Feng, et al.
Published: (2024)

Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges
by: Chunbao Jiao, et al.
Published: (2026)

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives
by: Yingjie Wang, et al.
Published: (2024)

Immune and Immune‐Integrated Organoids as NextGeneration Platforms for Disease Modeling
by: Kimiya Rashidan, et al.
Published: (2025)

Oncolytic Therapy: Delivery System and New Therapeutic Strategies for Cancer
by: Sikan Jin, et al.
Published: (2026)

Cancer Neuroscience: Innovative Conception and Emerging Strategy of Therapy
by: Ting Wang, et al.
Published: (2026)

The application of the combination between artificial intelligence and endoscopy in gastrointestinal tumors
by: Shen Li, et al.
Published: (2024)

Systematic Identification of Molecular Signatures Dictating Therapeutic Effects of Clinically First‐Line Chemotherapy Regimens for Human Gastric Cancer Patients Based on Organoid Model
by: Jingwei Yang, et al.
Published: (2026)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
by: TingDan Hu, et al.
Published: (2024)

RNA Regulatory Networks: Key Hubs in the Panorama of Cancer and Emerging Therapeutic Targets
by: Xuan Yin, et al.
Published: (2026)

Gene and RNA Editing: Revolutionary Approaches to Treating Diseases
by: Jia‐Mei Li, et al.
Published: (2025)

Low Dose of IL‐2 Application for Graft‐Versus‐Host Disease Prophylaxis Following Haploidentical Stem Cell Transplantation
by: Zheng‐Li Xu, et al.
Published: (2026)

SMARCAL1: a new target for taming tumor immune evasion
by: Ting Xiao, et al.
Published: (2024)

Sepsis: the evolution of molecular pathogenesis concepts and clinical management
by: Zhongxue Feng, et al.
Published: (2025)

Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2‐Negative Luminal B Breast Cancer: A Prospective, Single‐Center, Single‐Arm, Phase II Trial (DANCER)
by: Yunxiang Zhou, et al.
Published: (2025)

Gut microbiota in health and disease: advances and future prospects
by: Yusheng Zhang, et al.
Published: (2024)

Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia‐related chronic kidney disease
by: Jing Liu, et al.
Published: (2024)

Gene editing therapy for cardiovascular diseases
by: Xinyu Wu, et al.
Published: (2024)

The role of ubiquitination in health and disease
by: Yan Liao, et al.
Published: (2024)

Role of hydrogen sulfide in health and disease
by: Yu‐Qing Jin, et al.
Published: (2024)

High glutamine increases stroke risk by inducing the endothelial‐to‐mesenchymal transition in moyamoya disease
by: Qiheng He, et al.
Published: (2024)

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer
by: Yunfang Yu, et al.
Published: (2025)

Clinical glycoproteomics: methods and diseases
by: Yujia Wang, et al.
Published: (2024)

Human Endogenous Retroviruses and Diseases
by: Can Chen, et al.
Published: (2025)

Protein palmitoylation: biological functions, disease, and therapeutic targets
by: Yan‐Ran Qian, et al.
Published: (2025)

PACLseq: A Standalone Diagnostic Method for Ph‐Like Acute Lymphoblastic Leukemia Using Nanopore Sequencing
by: Hang Zhang, et al.
Published: (2025)

Histone Modifications in Cardiovascular Disease: Mechanisms and Therapeutic Opportunities
by: Yu Zheng, et al.
Published: (2026)

Radiofrequency ablation: mechanisms and clinical applications
by: Jianhua Wu, et al.
Published: (2024)

Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B‐Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling
by: Yong Yang, et al.
Published: (2025)

Endothelial dysfunction: molecular mechanisms and clinical implications
by: Xia Wang, et al.
Published: (2024)

Implant Renal Injury‐Responsive Cells to Supplement Erythropoietin and Protect Kidney Injury
by: Hao Nie, et al.
Published: (2025)

Type‐I‐interferon‐responsive microglia: participates in cerebral development and disease
by: Hua Guo, et al.
Published: (2024)

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets
by: Shen'er Qian, et al.
Published: (2024)

Phase I Clinical Trial of CVL218, a Novel PARP1/2 Inhibitor, in Patients with Advanced Solid Tumors
by: Zihong Chen, et al.
Published: (2025)

Downregulating Platelet Endothelial Cell Adhesion Molecule‐1 Enhances Learning and Memory and Alleviates Hallmark Pathologies in Alzheimer's Disease
by: Qiuzhi Zhou, et al.
Published: (2026)